GlaxoSmithKline is making its largest oncology acquisition in years with a $10.6 billion deal for US-based cancer drug developer Nuvalent, betting that a…
US stock-index futures advanced on Tuesday as chipmakers extended their rebound and easing tensions in the Middle East helped restore some appetite for…
SpaceX’s blockbuster IPO is attracting exactly the kind of demand many expected from Elon Musk’s most ambitious company. The offering is now reportedly…
The upcoming initial public offering of SpaceX is triggering a wave of investor interest across Asia, with market participants seeking exposure to the…
